0001209191-15-064627.txt : 20150807
0001209191-15-064627.hdr.sgml : 20150807
20150807161331
ACCESSION NUMBER: 0001209191-15-064627
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150805
FILED AS OF DATE: 20150807
DATE AS OF CHANGE: 20150807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Pharma plc
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAMPTON GEORGE P
CENTRAL INDEX KEY: 0001650147
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 151037623
MAIL ADDRESS:
STREET 1: C/O HORIZON PHARMA PLC
STREET 2: 520 LAKE COOK ROAD, STE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60015
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-08-05
0
0001492426
Horizon Pharma plc
HZNP
0001650147
HAMPTON GEORGE P
C/O HORIZON PHARMA PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
D04 C5Y6
IRELAND
0
1
0
0
See remarks
Stock Option (Right to Buy)
26.01
2025-03-31
Ordinary Shares
17000
D
Stock Option (Right to Buy)
29.22
2025-04-30
Ordinary Shares
20000
D
Restricted Stock Units
Ordinary Shares
8000
D
Restricted Stock Units
Ordinary Shares
20000
D
Performance Share Units (PSU)
Ordinary Shares
132000
D
25% of the shares subject to the option vest and become exercisable on the first anniversary of the vesting commencement date of April 1, 2015, and the remaining shares vest in 36 equal monthly installments thereafter.
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The restricted stock units vest 25% annually on each anniversary of the vesting commencement date of April 1, 2015.
Each PSU represents a contingent right to receive ordinary shares of the Issuer, based on the Issuer's level of total shareholder return, as measured on December 22, 2017, March 22, 2018 and June 22, 2018 or based on the level of total shareholder return through any earlier change in control. For such purposes, total shareholder return means the percentage change in the price of the Issuer's ordinary shares on a compounded annual basis, plus the value of reinvested dividends. The number of shares issued may range from zero (0) shares to the maximum number of shares reported in column 3 of this report.
The Reporting Person is EVP, Global Orphan Business Unit and International Operations of the Issuer.
/s/ Meghanne Downes, Attorney-in-Fact
2015-08-07
EX-24.3_599316
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Paul W. Hoelscher, Brian Beeler, Miles McHugh and Meghanne Downes of
Horizon Pharma plc (the "Company"), signing individually, the undersigned's true
and lawful attorney-in fact and agent to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each of the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact
shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 3rd day of August, 2015.
/s/ George P. Hampton